Your browser doesn't support javascript.
loading
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Lewis, Clinton; Kim, Haesook T; Roeker, Lindsey E; Cutler, Corey; Koreth, John; Nikiforow, Sarah; Armand, Philippe; Gootpu, Mahasweta; Romee, Rizwan; Glotzbecker, Brett; Nageshwar, Prashant; Antin, Joseph H; Alyea, Edwin P; Richardson, Paul; Soiffer, Robert J; Ho, Vincent T.
Afiliação
  • Lewis C; Department of Haematology, Auckland City Hospital, Auckland, New Zealand.
  • Kim HT; Department of Data Sciences, Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Roeker LE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cutler C; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Koreth J; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Nikiforow S; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Armand P; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Gootpu M; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Romee R; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Glotzbecker B; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Nageshwar P; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Antin JH; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Alyea EP; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Richardson P; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Soiffer RJ; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts.
  • Ho VT; Department of Medical Oncology, Division of Hematologic Malignancies, Dana-Farber Cancer, Institute, Harvard Medical School, Boston, Massachusetts. Electronic address: Vincent_Ho@DFCI.Harvard.Edu.
Biol Blood Marrow Transplant ; 26(3): 529-539, 2020 03.
Article em En | MEDLINE | ID: mdl-31678537

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Veno-Oclusiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nova Zelândia